APA (7th ed.) Citation

SM, W., AJ, V., NN, F., & ZZ, T. (2023). Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis. World journal of oncology, 14(6), 518. https://doi.org/10.14740/wjon1685

Chicago Style (17th ed.) Citation

SM, Warli, Velaro AJ, Firsty NN, and Tala ZZ. "Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis." World Journal of Oncology 14, no. 6 (2023): 518. https://doi.org/10.14740/wjon1685.

MLA (9th ed.) Citation

SM, Warli, et al. "Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis." World Journal of Oncology, vol. 14, no. 6, 2023, p. 518, https://doi.org/10.14740/wjon1685.